100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (PARENTHETICAL) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDER'S DEFICIT link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Nature of the Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - License and Collaboration Agreements link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Population Health Partners link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Defined Contribution Plan link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Net Loss per Share link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Selected Quarterly Financial Data (unaudited) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Subsequent Events (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Prepaid Expenses and Other Current Assets (Table) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Nature of the Business and Basis of Presentation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Summary of Significant Accounting Policies - Summary of Estimated Useful Life of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Fair Value Measurments - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Fair Value Measurements (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Inventory (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Inventory - Schedule Of Presents Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - License and Collaboration Agreements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Population Health Partners (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Commitments and Contingencies - Schedule of operating lease expense (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Common Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Fair Values and Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Stock-Based Compensation - Summary of Stock Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Stock-Based Compensation - Summary of Share Based Compensation Expense Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Defined Contribution Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Net Loss per Share - Schedule of Earning Per Share, Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Net Loss per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Selected Quarterly Financial Data (unaudited) - Schedule of Quarterly Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Selected Quarterly Financial Data (unaudited) - Schedule of Quarterly Financial Information (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Segment Reporting - Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Segment Reporting - Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink Statement [Line Items] Statement [Line Items] Subsequent Events (Unaudited) Subsequent Events Unaudited [Text Block] Subsequent events (unaudited). Deferred offering costs in accrued expenses Deferred offering costs in accrued expenses Deferred offering costs in accrued expenses Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock, shares Stock Issued During Period Shares Series A Convertible Preferred Stock Stock Issued During Period Shares Series A Convertible Preferred Stock Cybersecurity Risk Board of Directors Oversight [Text Block] Increase (Decrease) in Accounts Receivable Accounts receivable Accounts receivable Research development and regulatory milestone. Research Development And Regulatory Milestone [Member] Research Development And Regulatory Milestone Plan Name Plan Name [Domain] Number of quarterly installments for vesting succeeding period Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Succeeding Period Share based compensation arrangement by share based payment award vesting number of quarterly installment succeeding period. Convertible preferred stock, liquidation preference Temporary Equity, Liquidation Preference Adimab Platform Transfer Agreement [Member] Adimab Platform Transfer Agreement [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code PHP Warrants [Member] PHP Warrants Outstanding [Member] PHP Warrants Outstanding [Member] Federal research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Balances, shares Balance, shares Shares, Outstanding Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueGrantdatefairvalueperwarrant ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueGrantdatefairvalueperwarrant Grant date fair value per warrant Auditor Name Milestone payment. Milestone Payment Milestone payment Convertible preferred stock, shares issued Temporary Equity, Shares Issued Fair Value Level 2 Fair Value, Inputs, Level 2 [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Sale Leaseback Transaction, Monthly Rental Payments Monthly rental payments Accrued Inventory Accrued Inventory Accrued inventory 2020 Equity Incentive Plan [Member] Equity incentive plan. Equity Incentive Plan [Member] Accrued Liabilities [Abstract] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] Two Thousand And Twenty Two Employee Stock Purchase Plan [Member] 2022 Employee Stock Purchase Plan [Member] Description of income tax benefit Income Tax Examination, Description Preferred Stock [Text Block] Convertible Preferred Stock Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Product and Service Product and Service [Axis] Effect of exchange rate changes on cash and cash equivalents Effect Of Exchange Rate Changes On Cash And Cash Equivalents Effect Of Exchange Rate Changes On Cash And Cash Equivalents Finite-Lived Intangible Assets by Major Class Finite-Lived Intangible Assets by Major Class [Axis] Percentage of options vesting Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Shares repurchased Stock Repurchased During Period, Shares Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock, Shares Noncash Investing and Financing Items [Abstract] Supplemental disclosure of non-cash investing activities: Related Party Transaction [Line Items] Related Party Transaction [Line Items] Cybersecurity Risk Management Processes Integrated [Text Block] Equity [Text Block] Common Stock Title and Position [Axis] Class of Warrant or Right [Axis] Sale of Stock [Domain] Cash and Cash Equivalents Cash and Cash Equivalents [Domain] Acquired in-process research and development Acquired In Process Research And Development Acquired in-process research and development. Cost of Product Revenue [Member] Cost of Product Revenue [Member] Cost Of Product Revenue [Member] Classification and Accretion of Convertible Preferred Stock Classification And Accretion Of Convertible Preferred Stock Policy [Text Block] Classification and Accretion of Convertible Preferred Stock. Entity Central Index Key Entity Central Index Key Warrant [Member] PHP Warrant Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Auditor Opinion [Text Block] Auditor Opinion Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Tax Year2040 Tax Year2040 [Member] Identified as tax year 2040. Common stock, shares issued Common Stock, Shares, Issued Common Stock, Shares, Issued, Total Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Exercise of stock options Exercise of stock options Exercise of stock options Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Schedule of quarterly financial information Quarterly Financial Information [Table Text Block] Preferred Stock [Member] Entity Address, State or Province Entity Address, State or Province Stock Issued During Period, Value, Employee Stock Purchase Plan Proceeds from issuance of common stock under the employee stock purchase plan Issuance of common stock under the employee stock purchase plan Revision of Prior Period [Axis] Class of Warrant or Right [Table] Wu Xi Commercial Manufacturing Services Agreement. Wu Xi Commercial Manufacturing Services Agreement [Member] WuXi Commercial Manufacturing Services Agreement [Member] Prepaid Compensation And Related Expenses Prepaid compensation and related expenses Prepaid compensation and other Pemivibart Research and Development Expense Amount of expense for research and development allocated to the Pemivibart program. Pemivibart Retirement Plan Name [Domain] Property Plant And Equipment Estimated Useful Lives Property Plant And Equipment Estimated Useful Lives1 Property Plant And Equipment Estimated Useful Lives1 Lease, Cost [Abstract] Lease cost Accrued Upfront Fee. Accrued Upfront Fee Accrued Upfront Fee Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Treasury Stock, Common, Shares Treasury Stock, Common, Shares Treasury Stock, Common, Shares Treasury Stock, Common, Shares Cover [Abstract] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Earnings Per Share, Basic Net loss per share attributable to common stockholders, basic and diluted Net loss per share attributable to common stockholders, basic Valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Capitalized research and development Operating expenses: Operating Expenses [Abstract] Indefinite Period Indefinite Period [Member] Indefinite period. Available For Sale Debt Securities [Member] Available For Sale Debt Securities [Member] Available For Sale Debt Securities [Member] Document Annual Report Document Annual Report Unallocated research and development expenses Unallocated research and development expenses Unallocated research and development expenses Two Thousand And Twenty One Employee Stock Purchase Plan Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Two Thousand And Twenty One Employee Stock Purchase Plan Member 2021 Employee Stock Purchase Plan [Member] Unrealized Gains Unrealized Gain on Marketable Securities Unrealized Gain on Marketable Securities Deferred tax assets Operating lease liability Deferred tax assets Operating lease liability Operating lease liability WuXi Cell Line License Agreement. Wu Xi Cell Line License Agreement [Member] Cell Line License Agreement [Member] Summary of Estimated Useful Life of Property and Equipment Estimated Useful Life of Property and Equipment [Table text block ] Estimated Useful Life of Property and Equipment. Share-Based Payment Arrangement, Expense Stock-based compensation Distributors Accounted Accounts Receivable Distributors Accounted Accounts Receivable Third-party specialty distributors accounted accounts receivable 2027 Purchase Obligation, to be Paid, Year Four Other comprehensive income (loss) Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] Accumulated Deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Plan Name Plan Name [Axis] Segment Reporting [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Shares Beginning Balance Number of Shares Ending Balance Due from Related Party Due From Related Party Due From Related Party Current assets: Assets, Current [Abstract] Optimization Completion Fee. Optimization Completion Fee Optimization completion fee payable to related party Payments for offering costs Payments for offering costs Payments for offering costs Payments for offering costs Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cost, Depreciation and Amortization Cost, Depreciation and Amortization, Total Depreciation and amortization expense Adimab [Member] Adimab [Member] Royalty expense Royalty Expense Product and Service [Domain] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Tax Period Tax Period [Domain] Operating loss carryforwards Operating Loss Carryforwards Operating Loss Carryforwards, Total Property and equipment, net Property, Plant and Equipment, Net Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Total Retirement of treasury shares, shares Shares retired Treasury Stock, Shares, Retired Schedule of Preferred Stock Temporary Equity [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Recurring Fair Value, Recurring [Member] Product Revenue Net Policy Text Block Product Revenue Net Policy Text Block Product Revenue, Net ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCommonsharesoutstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCommonsharesoutstanding Common shares outstanding Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis Convertible Debt, Total Convertible Debt Convertible Debt Common stock, par value Common Stock, Par or Stated Value Per Share Stock Options [Member] Other Commitments [Abstract] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] 2025 Purchase Obligation, to be Paid, Year Two Temporary Equity Stock Repurchased During Period Value Temporary equity stock repurchased during period value. Temporary equity, Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Accounts Receivable Accounts Receivable [Policy Text Block] Statement of Cash Flows [Abstract] Counterparty Name [Axis] Series C convertible preferred stock. Series C Convertible Preferred Stock [Member] November 15, 2028 [Member] Fifteen November Two Thousand Twenty Eight Member Fifteen November Two Thousand Twenty Eight [Member] Acquired in-process research and development expense. Acquired In Process Research And Development Expense Acquired in-process research and development Accrued professional and consultant fees Accrued Professional Fees Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Intangibles Deferred Tax Assets, Goodwill and Intangible Assets Other Deferred Tax Assets, Other Unvested Restricted Common Stock [Member] Restricted Stock [Member] Equity Components Equity Components [Axis] Entity Address, Address Line One Entity Address, Address Line One Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Property, Plant and Equipment [Line Items] Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage Percentage of eligible participants of non-elective contributions Weighted-average remaining contractual term (Years) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Total other income, net Nonoperating Income (Expense) Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Security for sale offering Partners' Capital Account, Public Sale of Units Net of Offering Costs Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Marketable Securities Entity Voluntary Filers Entity Voluntary Filers Amendment Flag Amendment Flag Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] 2020 Employee Stock Purchase Plan Member Two Thousand And Twenty Employee Stock Purchase Plan Two Thousand And Twenty Employee Stock Purchase Plan Member Deferred Offering Costs In Accounts Payable Deferred Offering Costs In Accounts Payable Deferred offering costs in accounts payable ATM Facility [Member] ATM Facility [Member] Increase (Decrease) in Operating Lease Liability Operating lease liabilities Tax credit carryforward expiration term Tax Credit Carryforward Expiration Term Description of tax credit cexpiration term. Operating Lease, Liability, Noncurrent Operating lease liabilities, non-current Operating lease liability Domestic Tax Authority Domestic Tax Jurisdiction [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Sale of stock, price per share Sale of Stock, Price Per Share Net loss Net Loss Net loss attributable to common stockholders Ownership Change Description A description of ownership change. Description of ownership change Inventory, Noncurrent Inventory, Noncurrent, Total Inventory, net Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Common stock, option Exercised Exercise of stock options, shares Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Research and Development Expense [Member] Research and Development [Member] Defined Contribution Plan, Cost Defined contribution amount Equity Component Equity Component [Domain] Statistical Measurement Statistical Measurement [Domain] Document Financial Statement Error Correction Flag Document Financial Statement Error Correction [Flag] Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent, Total Unrealized loss on available-for-sale securities, net of tax Unrealized gain, net of tax Share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Furniture and Fixtures [Member] Furniture and Fixtures [Member] Treasury Stock, Common [Member] Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than) Share Based Compensation Arrangement By Share Based Payment Award Options Exercise Price Percentage Of Fair Value Of Common Stock Share based compensation arrangement by share based payment award options exercise price percentage of fair value of common stock. Cybersecurity Risk Management Processes Integrated [Flag] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Preferred Stock, Shares Issued Preferred Stock, Shares Issued, Total Preferred stock shares issued Distributer Three [Member] Distributer Three [Member] Distributer 3 Proceeds from Stock Options Exercised Proceeds from exercises of stock options Related-Party Amounts Related-Party Amounts Related-party amounts Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under the employee stock purchase plan, shares Deferred Tax Assets Warrant Expense Deferred Tax Assets Warrant Expense Warrant expense Deferred tax liabilities Operating lease right-of-use assets Deferred tax liabilities Operating lease right-of-use assets Operating lease right-of-use assets Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Class of Stock Class of Stock [Domain] License and Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Common stock, shares outstanding Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Finite-Lived Intangible Assets, Major Class Name Finite-Lived Intangible Assets, Major Class Name [Domain] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Preferred stock, par value Preferred stock per share Preferred Stock, Par or Stated Value Per Share Research and development tax credits carryforwards Deferred Tax Asset, In-Process Research and Development AccruedResearchandDevelopmentCostsPolicyTextBlock AccruedResearchandDevelopmentCostsPolicyTextBlock Accrued Research and Development Costs Antidilutive Securities Antidilutive Securities [Axis] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Asset Acquisitions and Acquired In-Process Research and Development Expenses Asset Acquisitions And Acquired In Process Research And Development Expenses Policy [Text Block] Asset Acquisitions and Acquired In-Process Research and Development Expenses. Entity Interactive Data Current Entity Interactive Data Current Product [Member] Product revenue Quarterly Fee Quarterly Fee. Quarterly fee Summary of Marketable Securities Marketable Securities [Table Text Block] Related Party Transaction Related Party Transaction [Domain] Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Related Party Transactions Related Party Transactions Disclosure [Text Block] Statement of Financial Position Location, Balance [Axis] Statistical Measurement Statistical Measurement [Axis] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Operating Lease, Cost Operating lease cost Distributer 1 Distributer One [Member] Distributer One [Member] Asset fair value disclosure Assets, Fair Value Disclosure Assets, Fair Value Disclosure, Total Related Party Related and Nonrelated Parties [Domain] Lease, Cost Total lease cost Total lease cost Amortized Cost Amortization Amortization, Total Research and Development Arrangement [Member] Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock [Member] Series A convertible preferred stock. Shares available for future issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Unrecognized stock based compensation expense, Weighted average recognition period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Machinery and Equipment [Member] Machinery and Equipment [Member] Purchase Obligation, to be Paid, Year One 2025 Deferred Tax Assets, Net Total net deferred tax assets Accrued employee compensation Accrued Employee Benefits, Current Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Income Statement Location Statement of Income Location, Balance [Axis] Cash and Cash Equivalents Cash and Cash Equivalents [Axis] Total assets Assets Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Tax Period Tax Period [Axis] PHP Member PHP Member PHP (member) Total deferred tax liabilities Deferred Tax Liabilities, Gross Total deferred tax liabilities Total deferred tax liabilities New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Entity Address, City or Town Entity Address, City or Town Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Equity [Abstract] Selected Quarterly Financial Information [Abstract] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Schedule of Utility Inventory [Table Text Block] Inventory Auditor Location Assets: Assets, Fair Value Disclosure [Abstract] Second Product. Second Product [Member] Second Product [Member] Effective Income Tax Rate Reconciliation, Percent [Abstract] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Costs of Revenue The aggregate costs of goods produced and sold and services rendered during the reporting period. Cost of product revenue Number of quarterly installments for vesting Share Based Compensation Arrangement By Share Based Payment Award Vesting Number Of Quarterly Installment Share based compensation arrangement by share based payment award vesting number of quarterly installment. Repurchased common stock, per share Share Price Purchase price per share Numerator: Net Income (Loss) Attributable to Parent [Abstract] Revision of Prior Period [Domain] Schedule of Segment Reporting Information, by Segment [Table] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Unaudited Interim Financial Information Credit Loss, Financial Instrument [Policy Text Block] Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Stock-based compensation Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Number of shares of common stock authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Series A Preferred Stock [Member] Series A Preferred Stock [Member] Prepaid Expense and Other Assets, Current [Abstract] Unrecognized tax benefits accrued for interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total Fair Value Disclosures [Abstract] Entity Public Float Entity Public Float Cash fees Cash Fees Fees to be paid in cash Issuance of common stock Stock Issued During Period, Value, New Issues Issuance of common stock, net of issuance costs Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets Chief Executive Officer [Member] Chief Executive Officer [Member] Royalty, Percentage of Sublicense Consideration. Royalty Percentage Of Sublicense Consideration Royalty percentage of sublicense consideration Vesting of restricted common stock from early-exercised options Stock Issued During Period, Value, Stock Options Exercised Potential milestone payment. Potential Milestone Payment Potential milestone payment Current liabilities: Liabilities, Current [Abstract] Prepaid Expenses Other Current Assets Prepaid Expenses Other Current Assets [Text Block] The entire disclosure for prepaid expenses and other current assets. Fair Value Fair Value Assets, Fair Value Adjustment Accrued Liabilities Accrued expenses Cash and Cash Equivalents [Member] Cash And Cash Equivalents [Member] Document Type Document Type Repurchase of unvested restricted common stock (in shares) Stock Repurchased and Retired During Period, Shares Repurchase of unvested restricted common stock (in shares) Title of 12(b) Security Title of 12(b) Security Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Statement of Financial Position Location, Balance [Domain] Schedule of Operating lease expense Lease, Cost [Table Text Block] Cybersecurity Risk Management, Strategy, and Governance [Line Items] DeferredOfferingCostsPolicyTextBlock DeferredOfferingCostsPolicyTextBlock Deferred Offering Costs Statement of Stockholders' Equity [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of stock options exercised Research and development Research and development expense Research and Development Expense Research and Development Expense, Total Third Party Logistic distributors accounted gross sales Third Party Logistic Distributors Accounted Gross Sales Third Party Logistic Distributors Accounted Gross Sales Cash paid for amounts included in the measurement of lease liabilities VYD2311 Research and Development Expense Amount of expense for research and development allocated to the VYD2311 program VYD2311 Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted Fair value transfers between levels transfers amount. Fair Value Transfers Between Levels Transfers Amount Transfers between level 3 Sales Agreement [Member] Sales Agreement [Member] Sales Agreement [Member] Asset Class [Domain] Leases Lessee, Leases [Policy Text Block] Retirement of treasury shares Treasury Stock, Retired, Par Value Method, Amount Schedule of Weighted Average Fair Values and Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Adimab Collaboration Agreement [Member] Adimab Collaboration Agreement [Member] Adimab Collaboration Agreement. Population Health Partners Other Commitment Disclosure [Text Block] Other Commitment Disclosure [Text Block] Available-for-sale securities held, remaining maturities greater than twelve months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price Financial Instruments [Domain] Shelf Registration Statement [Member] Shelf Registration Statement [Member] Present value of operating lease liability Present value of operating lease liability Present value of operating lease liability Class of Warrant or Right [Line Items] Sale of Stock [Axis] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] License Agreement [Abstract] License Agreement Abstract. Payments for Repurchase of Common Stock Payments for repurchases of unvested restricted common stock Acquired In Process Research And Development Expense [Member] Acquired In Process Research And Development Expense [Member] Statement of Comprehensive Income [Abstract] Retirement Plan Name [Axis] Income Taxes Income Tax Disclosure [Text Block] Temporary equity, Conversion of convertible preferred stock to common stock, shares Temporary equity stock issued during period shares conversion of share. Temporary Equity Stock Issued During Period Shares Conversion Of Share Schedule of Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Defined Contribution Plan Disclosure [Line Items] Selling, general and administrative Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Series B Preferred Stock [Member] Series B Preferred Stock [Member] Series B Preferred Stock Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Shares repurchased, Fair value Stock Repurchased During Period, Value Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Accounts payable Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total Entity Address, Address Line Two Entity Address, Address Line Two Liabilities, Preferred Stock and Stockholders' Equity Liabilities and Equity [Abstract] First Product. First Product [Member] First Product [Member] Repurchase of unvested restricted common stock Stock Repurchased and Retired During Period, Value Document Period End Date Document Period End Date Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party Related Party Transaction Expenses From Transaction With Related Party November 15, 2030 [Member] Fifteen November Two Thousand Thirty [Member] Fifteen November Two Thousand Thirty [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount November 15, 2029 [Member] Fifteen November Two Thousand Twenty Nine [Member] Fifteen November Two Thousand Twenty Nine [Member] Present value adjustment Present value adjustment Present value adjustment 2026 Purchase Obligation, to be Paid, Year Three Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Accrued expenses Accrued Liabilities, Current Accrued Liabilities, Current, Total Other Research and Development Expense Recognized research and development Fair value of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Income tax expense (benefit) Trading Symbol Trading Symbol Balance Balance Equity, Attributable to Parent Total stockholders' equity Subordinated Borrowing, Interest Rate Borrowing rate Due To Related Parties Due To Related Parties Due To Related Parties Deferred Tax Assets, Gross Total gross deferred tax assets Long-Lived Tangible Asset [Axis] Class of Warrant or Right, Outstanding Exercisable common stock Beginning Balance Ending Balance Other Liabilities, Noncurrent Other Liabilities, Noncurrent, Total Other non-current liability Emerging Growth Company Emerging Growth Company Policy [Text Block] Emerging Growth Company Related Party Transactions [Abstract] Convertible preferred stock, shares authorized Temporary Equity, Shares Authorized Variable Lease, Cost Variable lease cost Property, Plant and Equipment [Table] Cybersecurity Risk Management, Strategy, and Governance [Table] Total unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Unrecognized stock based compensation expense IPR&D expense. In Process Research And Development Expense [Member] IPR&D Expense [Member] Third Party Specialty Distributors Accounted Gross Sales Third Party Specialty Distributors Accounted Gross Sales Third party specialty distributors accounted gross sales Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Summary of Share Based Compensation Expense Recognized Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Completion Fee. Completion Fee Completion fee Use of Estimates Use of Estimates, Policy [Policy Text Block] Lessee, operating lease, expiration date Lessee Operating Lease Expiration Date Lessee Operating Lease Expiration Date Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Conversion of convertible preferred stock to common stock Stock Issued During Period, Value, Conversion of Convertible Securities Issuance of restricted common stock upon early exercise of stock options Issuance of Restricted Common Stock Upon Early Exercise of Stock Options Issuance of Restricted Common Stock Upon Early Exercise of Stock Options Other Commitment Aggregate fee, Total Aggregate fee Scenario [Axis] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Marketable Securities, Policy [Policy Text Block] Marketable Securities Security Exchange Name Security Exchange Name Unrealized Loses Unrealized Loss on Marketable Securities Unrealized loss on marketable securities. Counterparty Name [Domain] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Operating Expenses Total operating costs and expenses Long-Lived Tangible Asset [Domain] Recognized expense Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized Class of Stock Class of Stock [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Fair value of common stock 401(k) Plan [Member] Four Hundred One K Plan Member Four Hundred One K Plan [Member] Interest Receivable, Current Interest receivable Maximum [Member] Maximum [Member] Total liabilities, preferred stock and stockholders' equity Liabilities and Equity Operating Lease, Right-of-Use Asset Operating lease right-of-use asset Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Retirement Benefits [Abstract] Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per share attributable to common stockholders, diluted Leasehold Improvements [Member] Leasehold Improvements [Member] Entity Ex Transition Period Entity Ex Transition Period Total liabilities Liabilities Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Total current assets Assets, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Net cash (used in) provided by investing activities Agency Securities [Member] Issuance of common stock, shares Stock Issued During Period, Shares, New Issues Issuance of common stock, net of issuance costs, Shares Percentage deduction of annual taxable income. Percentage Deduction Of Annual Taxable Income Percentage deduction of annual taxable income. Realized gains or losses on marketable securities recognized Realized Investment Gains (Losses) Realized Investment Gains (Losses), Total Change in deferred tax asset valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Entity Filer Category Entity Filer Category Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Exercised Exercised Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of the Business and Basis of Presentation Purchases of marketable securities Purchases of marketable securities Payments to Acquire Marketable Securities Payments to Acquire Marketable Securities, Total Other income: Nonoperating Income (Expense) [Abstract] Deferred Tax Liabilities Depreciation Expense Deferred Tax Liabilities Depreciation Expense Depreciation expense Current Fiscal Year End Date Current Fiscal Year End Date Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Other segment items expense Other segment items expense Other segment items Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Convertible preferred stock, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Related Party Transaction [Axis] Aggregate Intrinsic Value, Outstanding Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Related Party Related and Nonrelated Parties [Axis] Other Other Accrued Liabilities Entity Registrant Name Entity Registrant Name Selected Quarterly Financial Data (unaudited) Quarterly Financial Information [Text Block] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Net Loss per Share Earnings Per Share [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Money Market Funds Money Market Funds [Member] Other current liability Other Liabilities, Current Weighted Average Number of Shares Outstanding Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted-average common shares outstanding, basic Marketable Securities [Abstract] Interest Income (Expense), Nonoperating Interest Income (Expense), Nonoperating, Total Total revenue Issuance of convertible preferred stock Temporary Equity, Stock Issued During Period, Value, New Issues Increase (Decrease) in Other Current Liabilities Other current liabilities Common stock, shares authorized Common Stock, Shares Authorized Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Proceeds from issuance of common stock under the employee stock purchase plan Maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Proceeds from Sale and Maturity of Marketable Securities, Total Fair Value Level 1 Fair Value, Inputs, Level 1 [Member] Adintrevimab Research and Development Expense Amount of expense for research and development allocated to the Adintrevimab program. Adintrevimab Lessee, Operating Lease, Total Lease Space Lessee, operating lease total lease space. Lease space Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Related party expenses Costs and Expenses, Related Party Financial Instrument [Axis] Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Unvested Common Stock Options Schedule of Nonvested Share Activity [Table Text Block] General and Administrative Expense [Member] Selling, General and Administrative [Member] General and Administrative Expense Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock Member Stacy Price [Member] Stacy Price [Member] Warrant Expense (Policy) Warrant Expense (Policy) Warrant Expense Impairment loss Impairment, Long-Lived Asset, Held-for-Use Impairment, Long-Lived Asset, Held-for-Use, Total Revenue Recognition Revenue [Policy Text Block] Share-Based Payment Arrangement [Abstract] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Other Current Assets [Member] Accrued external research development and manufacturing expenses. Accrued External Research Development And Manufacturing Expenses Current Accrued external research, development and manufacturing costs Exercise Fee. Exercise Fee Exercise fee Proceeds from Issuance of Warrants Issuance of warrants for common stock Cybersecurity Risk Role of Management [Text Block] Debt securities, available-for-sale Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale, Total Accounting Policies [Abstract] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Stock Option Activity Annual gross revenue Annual gross revenue Annual gross revenue Cash and Cash Equivalents [Line Items] Income Tax Disclosure [Abstract] Stockholders' equity (deficit): Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Receivable [Domain] Percentage of income tax examination likelihood upon ultimate settlement Percentage of Income Tax Examination Likelihood Upon Ultimate Settlement Percentage of Income Tax Examination Likelihood Upon Ultimate Settlement. Drug delivery fees Drug Delivery Fees Drug delivery fees Statement [Table] Statement [Table] Segment Information Segment Reporting, Policy [Policy Text Block] Prepaid external research, development and manufacturing costs Prepaid External Research Development And Manufacturing Expense Current Prepaid external research development and manufacturing expenses. Weighted Average Remaining Contractual Term, Vested and Expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Preferred stock, shares authorized Preferred Stock, Shares Authorized Fair Value Adjustment of Warrants Warrant expense Warrant expense Entity File Number Securities Act File Number Segment Reporting Disclosure [Text Block] Segment Reporting Denominator: Earnings Per Share, Basic, Other Disclosure [Abstract] Adimab Assignment Agreement [Member] Adimab Assignment Agreement [Member] Adimab Assignment Agreement. Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash and cash equivalents Earnings Per Share [Abstract] Stock-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost State income taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Schedule of impact of the adoption [table text block] Schedule of impact of the adoption [table text block] Summary of the impact of the adoption Inventory Disclosure [Abstract] Contractual Obligation, Fiscal Year Maturity [Table Text Block] Schedule of Future Minimum Payments Under Non-cancellable Purchase Obligations Statement of Financial Position [Abstract] Tax Credit Carryforward Tax Credit Carryforward [Axis] IPO [Member] IPO [Member] Loss from operations Operating Income (Loss) Loss from operations Accrued Interest Receivables [Member] Accrued Interest Receivables [Member] Accrued Interest Receivables [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Entity Shell Company Entity Shell Company Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of common stock, net of issuance costs Proceeds from issuance of common stock, net of issuance costs Purchase Obligation Purchase Obligation Total lease payments Entity Tax Identification Number Entity Tax Identification Number Assets Assets [Abstract] Class of Warrant or Right [Domain] Entity Current Reporting Status Entity Current Reporting Status Weighted Average Remaining Contractual Term, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating loss carryforwards expiration Operating Loss Carryforwards Expiration Expiration date of operating loss carryforward. Total direct, external research and development expenses by program Total direct, external research and development expenses by program Total direct, external research and development expenses by program Subsequent Events [Abstract] Inventory Disclosure [Text Block] Inventory Previously Reported [Member] Document Fiscal Year Focus Document Fiscal Year Focus Preferred Stock, Value, Issued Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred stock (undesignated), $0.0001 par value; 10,000,000 shares authorized and no shares issued and outstanding at December 31, 2024 and December 31, 2023 Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Stock Issued During Period Value Series A Convertible Preferred Stock In Exchange For Assigned Rights License And Repurchased Common Stock Stock Issued During Period Value Series A Convertible Preferred Stock In Exchange For Assigned Rights, License And Repurchased Common Stock Receivable Type [Axis] Tax credit carryforward Tax Credit Carryforward, Amount City Area Code City Area Code Total current liability Liabilities, Current Schedule Of Prepaid Expenses And Other Current Assets Table [Text Block] Tabular disclosure of the carrying amounts of prepaid expenses and other current assets. Summary of Prepaid Expenses and Other Current Assets Inventory, Net Inventory, Net, Total Inventory, net Legal Costs, Policy [Policy Text Block] Patent Costs Inventory, Finished Goods, Gross Finished goods Federal statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Defined Contribution Plan Defined Contribution Plan [Text Block] Conversion of convertible preferred stock to common stock, shares Stock Issued During Period, Shares, Conversion of Convertible Securities Organization, Consolidation and Presentation of Financial Statements [Abstract] Local Phone Number Local Phone Number Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding Preferred stock shares outstanding Common shares repurchased Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Issuance of restricted common stock upon early exercise of stock options, share) Issuance of Restricted Common Stock Upon Early Exercise of Stock Options, Share Issuance of Restricted Common Stock Upon Early Exercise of Stock Options, Share Temporary Equity,Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock Temporary Equity Issued During Period Convertible Preferred Stock In Exchange For Assigned Rights License And Repurchased Common Stock Value Temporary Equity, Issued During Period Convertible Preferred Stock In Exchange For Assigned Rights License And Repurchased Common Stock, Value. Income Tax Jurisdiction [Axis] Income Tax Authority Income Taxes Income Tax, Policy [Policy Text Block] Fixed asset purchases in account payable and accrued expenses Fixed asset purchases in account payable and accrued expenses Purchases of property and equipment in accounts payable and accrued expenses Commitments and Contingencies Disclosure [Abstract] Treasury stock Treasury stock Treasury Stock, Value Treasury Stock, Value, Total Treasury stock, at cost; 0 shares and 468,751 shares at December 31, 2022 and December 31, 2021, respectively Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Summary of Net Deferred Tax Assets Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Royalty Based on Net Sales of Licensed Products, Percentage. Royalty Based On Net Sales Of Licensed Products Percentage Royalty Based on Net Sales of Licensed Products, Percentage Federal agency securities [Member] Federal agency securities [Member] Operating Lease, Liability, Current Operating lease liabilities, current Combined voting power on all classes of stock threshold Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Voting Interests Threshold share based compensation arrangement by share based payment award percentage of voting interests threshold. Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Operating lease right-of-use asset recognized under ASC 842 In Process Research and Development [Member] In Process Research and Development [Member] Income Tax Authority Income Tax Jurisdiction [Domain] Accumulated Deficit [Member] Retained Earnings [Member] Defined Contribution Plan [Table] Purchases of property and equipment Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Asset and Liabilities Measured at Fair Value on Recurring Basis Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Document Transition Report Document Transition Report Available for sale marketable securities Available for sale marketable securities Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Issuance of convertible preferred stock, shares Temporary Equity Stock Issued During Period Share New Issues Temporary Equity Stock Issued During Period Share New Issues. Distributer Two [Member] Distributer Two [Member] Distributer 2 Excercise price per share Exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Concentrations of Credit Risk, Significant Suppliers and License Rights Concentration Risk, Credit Risk, Policy [Policy Text Block] Auditor Firm ID Minimum [Member] Minimum [Member] Common Stock [Member] Common Stock [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Aggregate Intrinsic Value, Vested and Expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Other non-current assets Other non-current assets Increase (Decrease) in Other Noncurrent Assets Operating Lease, Right-of-Use Asset, Periodic Reduction Amortization of operating lease right-of-use assets Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Cash fee payment per month Cash fee payment per month Cash fee payment per month Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income Statement Location Statement of Income Location, Balance [Domain] Accounts Receivable, before Allowance for Credit Loss, Current Accounts Receivable Other non-current assets Other Assets, Noncurrent Other Assets, Noncurrent, Total Schedule of Inventory, Current [Table Text Block] Schedule of Inventory VYD Two Hundred Twenty Two DrugSubstance VYD Two Hundred Twenty Two DrugSubstance [Member] VYD Two Hundred Twenty Two DrugSubstance [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding PHP Warrant [Member] PHP Warrant [Member] PHP Warrant [Member] Scenario [Domain] Title and Position [Domain] Components of Deferred Tax Assets and Liabilities [Abstract] Common Stock Average Price Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Common stock, $0.0001 par value; 1,000,000,000 shares authorized, 119,835,162 shares issued and outstanding at December 31, 2024; 110,160,684 shares issued and outstanding at December 31, 2023 Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Payments for Royalties Payments For Royalties Prepaid Insurance Prepaid insurance Cash and Cash Equivalent [Table] A D G20 Drug Substance A D G20 Drug Substance [Member] ADG20 Drug Substance [Member] Operating Lease, Liability Operating cash flows related to operating leases Operating cash flows related to operating leases Delivery Fee. Delivery Fee Delivery fee Temporary Equity Stock Repurchased During Period Share Temporary equity stock repurchased during period share. Temporary equity, Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock, Shares Measurement Frequency Measurement Frequency [Axis] Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Commitments and contingencies (Note 9) Commitments and Contingencies Temporary equity, Conversion of convertible preferred stock to common stock Temporary equity stock issued during period value conversion of share Temporary Equity Stock Issued During Period Value Conversion Of Share Weighted-average common shares outstanding, diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reported Segment Revenues, and Significant Segment Expenses Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable Lessee, Operating Lease, Renewal Term Lease term Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Increase (Decrease) in Inventories Increase (Decrease) in Inventories, Total Inventory Inventory Cybersecurity Risk Management Third Party Engaged [Flag] Issuance of common stock at inception Stock Issued During Period Value Common Stock At Inception Stock Issued During Period Value Common Stock at Inception Operating Costs and Expenses [Abstract] Operating costs and expenses: Entity Small Business Entity Small Business Segment Reporting Information [Line Items] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Revenues Revenues, Total Revenues US Treasury Securities US Treasury Securities [Member] Common stock, conversion basis Common Stock, Conversion Basis Net amortization of premiums and accretion of discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Net amortization of premiums and accretion of discounts on marketable securities Convertible preferred stock shares reserved for future issuance Convertible Preferred Stock, Shares Reserved for Future Issuance Stock-Based Compensation Compensation Related Costs, Policy [Policy Text Block] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Beginning Balance Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Asset Class [Axis] PHP [Member] Population Health Partners [Member] Population Health Partners [Member] Deferred tax assets: Deferred Tax Assets, Gross [Abstract] State and Local Jurisdiction State and Local Jurisdiction [Member] Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease right-of-use asset recognized upon adoption of ASC 842 Percentage Of Total Number Of Shares Of Common Stock Outstanding Percentage of number of shares of common stock outstanding Percentage Of Total Number Of Shares Of Common Stock Outstanding Measurement Frequency Measurement Frequency [Domain] Share-Based Payment Arrangement, Recognized Amount [Abstract] 2021 Equity Incentive Plan [Member] Two Thousands Twenty One Equity Incentive Plan [Member] Two Thousands Twenty One Equity Incentive Plan [Member] Temporary Equity, Issuance of Series A convertible preferred stock in exchange for assigned rights, license and repurchased common stock, shares Temporary Equity Issued During Period Shares Convertible Preferred Stock In Exchange For Assigned Rights License And Repurchased Common Stock Temporary Equity, Issued During Period Shares Convertible Preferred Stock In Exchange For Assigned Rights License And Repurchased Common Stock. Valuation allowance Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Valuation Allowance, Total Convertible preferred stock, shares outstanding Temporary Equity, Shares Outstanding Work in process Inventory, Work in Process, Gross Third Party Logistic Distribution Agent Third Party Logistic Distribution Agent Third party logistic distribution agent accounted Fair Value Level 3 Fair Value, Inputs, Level 3 [Member] Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease Subsequent Events Subsequent Events [Text Block] Other income, net Other Nonoperating Gains (Losses) Cybersecurity Risk Management Positions or Committees Responsible [Flag] Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Costs and Expenses Costs and expenses Total operating costs and expenses Accrued expenses Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities, Total